Treatment Design Software Personalizes Medicine Plans for People with Movement Impairments

Treatment design software personalizes medicine plans for people with movement impairments

Impaired neuromusculoskeletal function due to conditions such as stroke, osteoarthritis, cerebral palsy, Parkinson's disease, limb amputation, spinal cord injury, traumatic brain injury and cancer is a leading cause of disability and affects roughly 1.7 billion people worldwide, including 19% of the U.S. adult population.

Could magic mushrooms help treat Parkinson’s patients?

The psychedelic drug has shown promise in improving mood, cognition, and motor symptoms

From fixed pulses to smart stimulation: Parkinson’s treatment takes a leap forward

Although the brain is our most complex organ, the ways to treat it have historically been rather simple. Typically, surgeons lesioned (damaged) a structure or a pathway in the hope that this would “correct the imbalance” that led to the disease. Candidate structures for lesioning were usually found by trial and error, serendipity or experiments in animals. While performing one such surgery in 1987, French neurosurgeon Alim-Louis Benabid noticed …

Place of Continuous Subcutaneous Infusion Systems in Parkinson Disease Management

Panelists discuss how continuous subcutaneous infusion systems should be strategically positioned within Parkinson disease management, typically as options for patients with advanced disease experiencing motor fluctuations despite optimized oral therapy.

Demand for support for Parkinson’s and other long-term conditions is up 30%

Demand for support for Parkinson’s cases has increased by 75% YoY, 33% for Arthritis, 22% for Fibromyalgia, and 11% for Multiple Sclerosis, according to new RedArc patient data, comparing 2024 with 2023. Collectively, this equates to a 30% increase for these long-term conditions. Due to a growing and ageing population, some of these conditions are […] Read this story Demand for support for Parkinson’s and other long-term conditions is up 30% on …

Demand for support for Parkinsons and other long-term conditions is up 30%, finds RedArc - IFA Magazine

Demand for support for Parkinson’s cases has increased by 75% YoY, 33% for Arthritis, 22% for Fibromyalgia, and 11% for Multiple Sclerosis, according to new RedArc patient data, comparing 2024 with 2023. Collectively, this equates to a 30% increase for these long-term conditions. Due to a growing and ageing population, some of these conditions are seeing an increase in diagnoses. For example, the UK Dementia Research Institute states that Parkin…